Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

INTRODUCTION: Triple negative breast cancer is associated with poorer prognosis and unresponsiveness to endocrine and anti-HER2 directed agents. Despite emerging data supporting the use of polyADP-ribose polymerase (PARP) inhibitors, complete and durable responses are rare and exploration of additio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Teng, Yvonne Hui-Fang, Tan, Wai-Jin, Thike, Aye-Aye, Cheok, Poh-Yian, Tse, Gary Man-Kit, Wong, Nan-Soon, Yip, George Wai-Cheong, Bay, Boon-Huat, Tan, Puay-Hoon
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219198/
https://ncbi.nlm.nih.gov/pubmed/21457545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2857
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars